A Genome-Wide Association Study of Overall Survival in Pancreatic Cancer Patients Treated with Gemcitabine in CALGB 80303
Federico Innocenti(AbbVie (United States)), Mark J. Ratain(University of Chicago), Dylan M. Glubb(QIMR Berghofer Medical Research Institute), Kouros Owzar(Duke University), Richard L. Schilsky(American Society of Clinical Oncology), Herbert I. Hurwitz(Duke Medical Center), Nancy Cox(University of North Carolina at Chapel Hill), Liewei Wang(Mayo Clinic), Michiaki Kubo(RIKEN Center for Integrative Medical Sciences), Hitoshi Zembutsu, Patrick Evans, Richard M. Goldberg(Ontario Institute for Cancer Research), Kathleen M. Giacomini(University of California, San Francisco), Taisei Mushiroda(RIKEN Center for Integrative Medical Sciences), Hedy L. Kindler(University of Chicago), Liang Li(Shanghai Public Health Clinical Center), Chen Jiang, Yusuke Nakamura(Tokyo University of Science), Donna Hollis(University of North Carolina at Chapel Hill), Paula N. Friedman(University of North Carolina at Chapel Hill), Howard L. McLeod(Unknown)
Cited by 110
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k